Pennsylvania 2025-2026 Regular Session

Pennsylvania House Bill HB1827

Introduced
9/2/25  

Caption

Providing for medical assistance coverage and insurance coverage of screening, prevention and treatment measures for osteoporosis as a result of menopause.

Impact

The bill aims to enhance coverage for medical assistance recipients by ensuring that screenings and treatments for osteoporosis are included as part of their health benefits. This will potentially improve health outcomes by facilitating earlier detection and intervention among those at risk for osteoporosis due to menopausal changes. By explicitly defining the terms of coverage, including preventative measures such as dietary supplements and physical therapy, HB1827 seeks to fortify the healthcare safety net for individuals undergoing menopause, thereby aligning state insurance practices with best medical recommendations for bone health.

Summary

House Bill 1827, also known as the Earlier Insurance Coverage for Osteoporosis Treatments Act, seeks to mandate insurance coverage for osteoporosis screening, prevention, and treatment measures for individuals experiencing menopause. The bill highlights the importance of addressing osteoporosis at an earlier stage by providing necessary medical assistance and insurance coverage for various preventative measures, including bone mineral density testing, hormonal and nonhormonal treatments, and related nutritional support. This legislation is grounded in the recognition that the incidence of osteoporosis significantly increases after menopause, making timely diagnosis and treatment crucial for affected individuals.

Sentiment

The sentiment surrounding HB1827 appears to be supportive, especially among advocates for women's health and osteoporosis prevention. Proponents argue that the comprehensive coverage is essential for addressing a significant health issue that affects many individuals, specifically postmenopausal women. The introduction of this bill indicates progress towards recognizing and mitigating the health risks associated with menopause, and the promotion of preventative healthcare strategies is generally seen as a positive development in public health discourse.

Contention

While the bill has garnered support, potential points of contention may arise around the logistical aspects of insurance coverage implementation, including cost implications for insurers and the adequacy of medical assistance programs to absorb the anticipated increase in services. Furthermore, stakeholders may have differing opinions on the best approaches to preventative care for osteoporosis and the role of state-mandated insurance coverage versus individual choice in healthcare decisions. These discussions could be pivotal as the bill progresses through legislative review.

Companion Bills

No companion bills found.

Previously Filed As

PA HB1345

In public assistance, providing for medical assistance coverage for menopause treatments.

PA S722

Establishes "New Jersey Menopause Coverage Act"; requires health insurance coverage of medically necessary perimenopause and menopause treatments.

PA HB1346

In casualty insurance, providing for menopause treatment coverage.

PA SB1122

In casualty insurance, providing for menopause treatment coverage.

PA S09230

Provides hospital, surgical and medical insurance coverage for perimenopausal and menopausal care and treatment.

PA A05444

Provides hospital, surgical and medical insurance coverage for perimenopausal and menopausal care and treatment.

PA A4642

Clarifies that testosterone therapy is covered treatment under the "New Jersey Menopause Coverage Act."

PA S4054

Clarifies that testosterone therapy is covered treatment under the "New Jersey Menopause Coverage Act."

PA SB1569

Creates new provisions relating to insurance coverage for treatment of certain menopause-related conditions

PA SF2048

A bill for an act relating to insurance coverage and Medicaid coverage for annual lung cancer screenings for at-risk individuals.

Similar Bills

PA HR435

Recognizing the month of May 2026 as "Osteoporosis Awareness Month" in Pennsylvania.

GA HR333

Osteoporosis Awareness and Prevention Month; May 2025; recognize

GA SR251

Osteoporosis Awareness and Prevention Month; recognize May 2025

TN SR0053

A RESOLUTION to designate May 2025 as "Osteoporosis Awareness and Prevention Month."

TN SJR0215

A RESOLUTION to commemorate Osteoporosis Awareness and Prevention Month.

NJ AJR142

Designates October 18 of each year as "Postmenopause Day" in New Jersey.

NJ SJR109

Designates October 18 of each year as "Postmenopause Day" in New Jersey.

CA AB641

Drug-Induced Movement Disorder Awareness Program.